Back
bluebird bio Vs. Vertex Pharmaceuticals Industry Stock Comparison
Sell
37
BLUE
bluebird bio
Last Price:
1.06
Seasonality Move:
16.47%
Buy
70
VRTX
Vertex Pharmaceuticals
Last Price:
422.82
Seasonality Move:
8.99%
Sell
37
bluebird bio (BLUE)
is a Sell
Is bluebird bio a Buy, Sell or Hold?
- The current bluebird bio [BLUE] share price is $1.06. The Score for BLUE is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- BLUE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
70
Vertex Pharmaceuticals (VRTX)
is a Buy
Is Vertex Pharmaceuticals a Buy, Sell or Hold?
- The current Vertex Pharmaceuticals [VRTX] share price is $422.78. The Score for VRTX is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- VRTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BLUE Stock Price Chart
What is bluebird bio's stock price today?
-
The bluebird bio share price today is $1.06
The current trend is relatively stagnant and BLUE is experiencing slight selling pressure.
VRTX Stock Price Chart
What is Vertex Pharmaceuticals's stock price today?
-
The Vertex Pharmaceuticals share price today is $422.78
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
BLUE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 51.46 | Buy |
| Chaikin Money Flow: | -2920780 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.91 - 1.11) | Buy |
| Bollinger Bands (100): | (0.95 - 1.55) | Sell |
VRTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.63 | Buy |
| Relative Strength Index (14 RSI): | 68.59 | Buy |
| Chaikin Money Flow: | 866749 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (393.68 - 409.68) | Buy |
| Bollinger Bands (100): | (402.61 - 427.89) | Buy |
BLUE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.99 | Buy |
| 20-day SMA: | 0.97 | Buy |
| 50-day SMA: | 1.19 | Sell |
| 200-day SMA: | 2.32 | Sell |
| 8-day EMA: | 1.01 | Buy |
| 20-day EMA: | 1.02 | Buy |
| 50-day EMA: | 1.15 | Sell |
| 200-day EMA: | 2.22 | Sell |
VRTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 409.6 | Buy |
| 20-day SMA: | 401.93 | Buy |
| 50-day SMA: | 407.91 | Buy |
| 200-day SMA: | 386.03 | Buy |
| 8-day EMA: | 411.9 | Buy |
| 20-day EMA: | 406.49 | Buy |
| 50-day EMA: | 407.38 | Buy |
| 200-day EMA: | 387.83 | Buy |
bluebird bio Earnings Growth & BLUE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and an increase next year of $0.71 per share.
Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.77 per share, an increase this year of $2.02 per share, and an increase next year of $1.15 per share.
bluebird bio Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Vertex Pharmaceuticals Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||